Powering multiplatform applications with axoCells™ motor neurons

uild high-quality in vitro neuromuscular disease models in 10 days.  

Ensure confidence in your workflow with high-quality axoCells^TM  motor neurons differentiated from human induced pluripotent stem cells (iPSCs). Derived from consenting donor fibroblasts, our motor neurons have been specifically developed for use in powerful in vitro monoculture and co-culture models, microfluidics platforms and for drug discovery.  

With Axol, you can rely on robust, physiologically relevant motor neurons that express the key markers (HB9, MAP2, LIM3 and ChAT2) and are assay-ready  in just 10 days using our Motor Neuron Maturation Accelerator Supplement. That means robust, physiologically relevant models of diseases such as ALS.